Analysts rate these 7 defensive picks Strong Buys.
Read MoreTrade Setup Buy Target $5.58 Sell Target $6.65 Arcadia Biosciences, Inc., an agricultural food ingredient company, develops and commercializes health and nutrition ingredient traits worldwide. The company offers a suite of agricultural productivity traits, including nitrogen use efficiency, water use efficiency and drought tolerance, salinity tolerance, and Wheat Yield traits. It also provides nutritional oils […]
Read MoreTrade Setup Buy Target $4.05 Sell Target $4.79 Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs in the United States. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in blood plasma and other bodily fluids.
Read MoreThis sector boasts both value and growth plays, and one trader says the group is “starting to fire on all cylinders.”
Read MoreTrade Setup Buy Target $1.52 Sell Target $1.73 Fortress Biotech, Inc. develops and commercializes pharmaceutical and biotechnology products. It markets dermatology products, such as Targadox for acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; Ala-Scalp and Triderm, which are used for the inflammatory […]
Read MorePlus, diplomatic tensions are rising between the U.S. and China, Netflix said the real competition in the streaming wars is with “linear TV,” and Morgan Stanley reported earnings.
Read MoreGoldman Sachs says October has historically been 25% more volatile since 1928.
Read MorePlus, Philip Morris and Altria called off their merger, WeWork’s CEO stepped down, and Saudi Aramco is finally going public.
Read MorePlus, good news out of Hong Kong, Hurricane Dorian is making its way to the U.S., and Box shares are soaring.
Read MoreThese 4 plays may be investors’ best best now.
Read More